Morgan Stanley analyst Patrick Wood downgraded Glaukos (GKOS) to Underweight from Equal Weight with a $120 price target While the firm thinks iDose is “a great product with a long-term trajectory,” it is struggling to see relative upside from here versus others stocks based on the current valuation. While there are also some “great assets in the pipeline,” these are some time out, the analyst added.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS: